Worldwide Epidemic

August 2, 2018 by C. Scott McMillin

Once such substances get a foothold in a region, they’re extremely hard to eradicate.

Topics: ,


In the News: Purdue Knew

June 25, 2018 by C. Scott McMillin

Maybe they reasoned that even if they were caught out, they could avoid the worst penalties.

Topics: , ,


Tapering off Anti-Depressants

May 14, 2018 by C. Scott McMillin

In the absence of complaints, the prescriber can be tempted to assume things are going well, when in fact they aren’t.

Topics: ,


The Business of Cures

May 7, 2018 by C. Scott McMillin

I’d feel better if I knew some in our brilliant science community were working hard on ways to taper patients, if just the most highly motivated, off the medications with a reduced risk of return to heroin.

Topics: , ,


Politics and Pharmacy

April 26, 2018 by C. Scott McMillin

A number of experts pointed out the risks associated with a dramatic increase in opioid prescribing. They were ignored in favor of others who downplayed those risks.

Topics: , ,


Selling Pills

April 12, 2018 by C. Scott McMillin

Maybe you’ll even suggest the medication. And the marketing team wants you to leave the doctor’s office with a prescription for that med.

Topics: ,


The Pain Patient Population

April 5, 2018 by C. Scott McMillin

Based on the vast number of prescriptions for opioid medications written by US practitioners over the past few decades, we’ve become the clear leaders in opioid prescribing.

Topics: , ,


A New ADHD Epidemic?

March 8, 2018 by C. Scott McMillin

Of course, if you work in addiction treatment, you probably see some of these same meds being abused by young adults, often beginning in college or grad school.

Topics:


Strange Bedfellows in the Pharma Lobby

February 26, 2018 by C. Scott McMillin

It isn’t PhDs in the white lab coats who show up at your doctor’s office to provide false or misleading information about drug safety.

Topics: , ,


Two Perspectives on Pain

February 22, 2018 by C. Scott McMillin

We may be stuck relying on the soft stuff– therapy, support, behavior change, even spiritual growth– all those icky-squicky things that neuroscientists struggle to quantify.

Topics: , ,


Subscribe to RecoverySI via Email

Join 2,543 other subscribers


New Content